Product Overview

Axiron® (testosterone) topical solution CIII is the first testosterone topical solution approved for application via an armpit (underarm) applicator. Axiron® is used to treat adult males who have low or no testosterone. Other forms of testosterone replacement therapy include: oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections and topical gels applied by the hands.

Axiron® has been licensed exclusively to Eli Lilly and has been launched in the United States of America, Canada, Australia, Germany, Brazil and South Korea.

Testosterone Deficiency

Testosterone deficiency is a clinical condition in which the testicles, hypothalamus or pituitary gland is affected by disease or damage that results in decreased testosterone production. Testosterone deficiency also may be known as hypogonadism or low testosterone.

Important safety and prescribing information can be obtained via

Axiron 2